Irreversible Electroporation Ablators Market Size, Share, Growth, and Industry Analysis, By Type (Generator,Part,Service), By Downstream Industry (Liver,Pancreas,Prostate,Other) and Regional Insights and Forecast to 2034

•   
•   
  

  Request a Free sample to learn more about this report

    

IRREVERSIBLE ELECTROPORATION ABLATORS MARKET OVERVIEW

The global Irreversible Electroporation Ablators Market size was USD 0.04 billion in 2025 and market is projected to touch USD 0.1 billion by 2034, exhibiting a CAGR of 10.89% during the forecast period from 2025 To 2034.

The United States irreversible electroporation ablators market size is projected at USD 0.0126 billion in 2025, the Europe irreversible electroporation ablators market size is projected at USD 0.0092 billion in 2025, and the China irreversible electroporation ablators market size is projected at USD 0.0118 billion in 2025.

Ablators for irreversible electroporation (IRE) are medical devices used in a minimally invasive process to kill certain cells or tissues. Electrodes that resemble needles are used in the ablation system, and imaging methods are used to place them. After that, the electrodes are subjected to high-voltage electrical pulses that generate an electric field that permanently damages cell membranes. When compared to other ablative methods, irreversible electroporation ablators have benefits including less harm to the surrounding tissues and perhaps quicker recovery durations.

There are various reasons why the market for irreversible electroporation ablators is expanding. First, IRE attracts patients and medical professionals looking for safer and more efficient alternatives to conventional cancer therapies. Second, it is extremely desirable since it can target tumour cells specifically while causing the least amount of harm to nearby healthy tissues. In addition, IRE is becoming more widely used as a result of technological developments and an increase in clinical evidence supporting its effectiveness. The market for ablators has grown as a result of these forces working together.

KEY FINDINGS

COVID-19 IMPACT

Frequent Lockdowns to Hamper the Market Growth

The global COVID-19 pandemic has been unprecedented and staggering, with the irreversible electroporation ablators market experiencing lower-than-anticipated demand across all regions compared to pre-pandemic levels. The sudden rise in CAGR is attributable to the market's growth and demand returning to pre-pandemic levels once the pandemic is over.

With resources being diverted to managing COVID-19 cases, the pandemic had disrupted healthcare systems across the globe. The need for the ablators temporarily decreased as a result of non-urgent medical operations, such as some cancer treatments, being cancelled or postponed. Additionally, the pandemic-related delays in supply chains and clinical trials had a negative impact on research and development efforts in the medical device sector. This delayed the market entry of new and improved IRE.

LATEST TRENDS

Development of Imaging Technology to Improve the Accuracy and Efficiency of IRE Ablation

The development of cutting-edge imaging techniques for process guidance is one of the newest trends in the irreversible electroporation ablators industry. With regard to precisely placing the electrodes and keeping track of treatment success, real-time imaging is essential. Imaging technology advancements, such as the incorporation of ultrasound, CT scan, or MRI guidance, can improve the accuracy and efficiency of IRE ablation.

• According to industry analysis, the adoption of ultrasound, CT, or MRI guidance in ≥80 % of procedures has significantly improved electrode placement accuracy and treatment efficiency in IRE systems

• A review published by J. Cardiovasc. Dev. Dis. noted that at least 44 % of preclinical IRE studies in catheter-based cardiac labs focus on ventricular myocardium, signaling growing utility beyond oncology

•   
•   
  

  Request a Free sample to learn more about this report

    

IRREVERSIBLE ELECTROPORATION ABLATORS MARKET SEGMENTATION

By Type

According to type, the market can be segmented into generator, part and service.

By Application

Based on application, the market can be divided into liver, pancreas, prostate and others.

DRIVING FACTORS

Growing Demand for Minimally Invasive Procedures is Driving IRE Market

One major driving factor of the irreversible electroporation ablators market growth is the growing demand for minimally invasive procedures. Compared to traditional cancer treatments such as surgery, IRE ablation offers a less invasive approach that can be performed with smaller incisions, resulting in reduced trauma to the patient. This aspect is highly attractive to both patients and healthcare providers as it can lead to several benefits, including shorter hospital stays, faster recovery times, reduced pain, and lower risk of complications. The desire for minimally invasive procedures has increased as patients seek treatments that can improve their quality of life and reduce the impact of invasive interventions.

Capability of IRE to Selectively Target and Eliminate Particular Cells is Growing its Demand

Another important motivating force is the capability of IRE ablation to selectively target and eliminate particular cells or regions. IRE ablation uses high-voltage electrical pulses to permanently harm cell membranes, unlike certain other ablative methods that rely on heat or extreme cold. This method minimizes damage to neighboring healthy tissues while enabling precision targeting of tumor cells. Due to its capacity to selectively destroy tissue, irreversible electroporation ablators are especially useful for treating tumors that are close to functionally important systems including blood arteries, nerves, or bile ducts. This focused strategy improves treatment results and lowers the danger of problems brought on by harming surrounding healthy tissues.

RESTRAINING FACTORS

Requirement for Specialized Training is Limiting the Growth of the Ablators Market

The requirement for specialized training and experience in performing the operation is one issue limiting the growth of the irreversible electroporation ablators sector. A skilled healthcare practitioner is needed for IRE ablation who is capable of precisely placing the electrodes and choosing the right treatment parameters. The procedure's complexity might prevent it from being widely used as it calls for a degree of competence that might not be present in all healthcare settings. In some areas or medical institutions, the growth and accessibility of IRE ablation may be constrained by the requirement for specialized training and experience.

• In the U.S., non‑thermal IRE accounted for over 80 % of ablation procedures in 2023, offering precise tumor targeting with reduced collateral damage

• FDA has granted Breakthrough Device designation to multiple IRE systems, expediting nearly 10 device approvals in the U.S. market

•   
•   
  Request a Free sample to learn more about this report

    

IRREVERSIBLE ELECTROPORATION ABLATORS MARKET REGIONAL INSIGHTS

Well-established Healthcare Infrastructure is Aiding North America to Dominate the IRE Market

North America is expected to dominate the irreversible electroporation ablators market share for several reasons. Firstly, the region benefits from a well-established healthcare infrastructure, including advanced medical facilities and imaging technologies, facilitating the adoption and utilization of advanced procedures such as IRE ablation. Secondly, North America has a strong focus on research and development, with a robust ecosystem of research institutions and medical device companies driving innovation in the field. Furthermore, the presence of key market players and their extensive marketing efforts in the region have contributed to the widespread awareness and adoption of ablation. Lastly, favorable reimbursement policies and a high healthcare expenditure in North America have further facilitated market dominance.

KEY INDUSTRY PLAYERS

Key Players Focus on R&D to Enhance the Effectiveness and Safety of their Systems

To dominate the irreversible electroporation sector, players are focusing on several strategies. They are investing in research and development to enhance the effectiveness and safety of their IRE ablation systems. Market players are also actively collaborating with healthcare providers to conduct clinical studies, gather evidence, and expand the application of ablation in different tumor types. Furthermore, they are engaging in extensive marketing efforts to create awareness among healthcare professionals and patients about the benefits of ablation, and they are establishing strong distribution networks to ensure widespread availability of their products.

• Pulse Biosciences: Listed among the leading two global IRE manufacturers, with over 56 % market consumption centered in North America

• Siric BRIO: Identified as a top-five global IRE manufacturer in official market reports

List of Top Irreversible Electroporation Ablators Companies

• AngioDynamics (U.S.)
• Pulse Biosciences (U.S.)

REPORT COVERAGE

This report covers the irreversible electroporation ablators market. The CAGR expected to be in during the forecast period, and also the USD value in 2025 and what it is expected to be in forecast period. The effect COVID-19 had on the market in the beginning of the pandemic. The latest trends taking place in this industry. The factors that are driving this market as well as the factors that are restraining the growth of industry. The segmentation of this market based on type and applications. The region leading in the industry and why they will continue to do so during the forecast period. Further, the key market players, what all is being done by them to stay ahead of their competition as well as retain their market positions. All these details are covered in the report.